Psychiatry - December 2008 - (Page 8)

Editor’s Message Issue Highlights, December 2008 Dear Colleagues: This month’s “Trend Watch” column examines the treatment of premenstrual dysphoric disorder by comparing antidepressant prescribing by obstetrician/gynecologists to psychiatrists and primary care physicians. An expert commentary on the data is provided by Dr. Uriel Halbreich, who is Director of Biobehavior Research and Professor of Psychiatry and OB/GYN at SUNY in Buffalo, New York. Next, in this month’s “The Interface” column, Sansone and Sansone review tricyclic antidepressants as well as venlafaxine, bupropion, and duloxetine with regards to their use for the treatment of chronic pain. The authors offer an interpretive comparison, as there are few head-to-head comparison studies. Next, Griffith discusses the diagnostic and therapeutic dilemmas psychiatrists may face when treating patients who struggle with chronic pain. She reviews, through case examples, a psychotherapeutic approach that may help patients with chronic pain feel supported. Next, Pies and Rogers provide a review on general medical drugs associated with depression. They review the methodological issues in assessing druginduced depression, its epidemiology, and hypotheses concerning its pathophysiology. They conclude with some practical recommendations for PCPs and other physicians. Next, Carroll et al describe the need for a new conceptual understanding of catatonia and propose the concept of katatonia, which describes a group of neuropsychiatric illnesses presenting with catatonic signs, as compared to catatonia, a term that the authors argue has come to inadequately represent, in recent times, simply a specifier of neuropsychiatric illnesses. This review addresses these clinical concepts and attempts to describe katatonia over the past few decades. A new rating scale and a conceptual outline for its clinical entity are also presented. In this month’s “Update on Blood Brain Barrier” column, Yarlagadda and Clayton explore the complicated interactions between neurotransmission, calcium signalling, and thermoregulation resulting from a challenged blood brain barrier in the hypothalamic region of the brain. Finally, in this month’s “Research to Practice” column, Dr. Steve Targum interviews the psychologist, Richard S.E. Keefe, who is Professor in the Department of Psychiatry and Behavioral Sciences at Duke University Medical School in Durham, North Carolina. Keefe discusses his research on the neurocognitive deficits of schizophrenia and offers his insights into the diagnostic, prognostic, and treatment implications for cognitive assessments in schizophrenia. Sincerely, Business Staff EDITOR Amir H. Kalali, MD Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc.; Professor of Psychiatry, University of California, San Diego, California FOUNDING EDITOR Wade H. Berrettini, MD, PhD Karl E. Rickels Professor of Psychiatry, Director, Center for Neurobiology and Behavior, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania PRESIDENT/GROUP PUBLISHER Robert L. Dougherty Matrix Medical Communications Edgemont, Pennsylvania PARTNER Patrick D. Scullin Matrix Medical Communications Edgemont, Pennsylvania VICE PRESIDENT, BUSINESS DEVELOPMENT Joseph J. Morris Matrix Medical Communications Edgemont, Pennsylvania VICE PRESIDENT, EXECUTIVE EDITOR Elizabeth A. Klumpp Matrix Medical Communications Edgemont, Pennsylvania ASSOCIATE EDITOR Colleen M. Hutchinson Matrix Medical Communications Edgemont, Pennsylvania ASSOCIATE EDITOR Kimberly B. Chesky Matrix Medical Communications Edgemont, Pennsylvania NATIONAL SALES MANAGER Brad A. Lacey Matrix Medical Communications Edgemont, Pennsylvania EDITORIAL CORRESPONDENCE should be directed to Executive Editor, Psychiatry 2008, Matrix Medical Communications, 4975 West Chester Pike, PO Box 445, Edgemont, PA 19028-0445. Tollfree: (866) 325-9907; Phone: (610) 325-9905; Fax: (610) 3259906; E-mail: eklumpp@matrixmedcom.com INDEXING— PsycINFO, CINAHL (Cumulative Index to Nursing and Allied Health Literature®), CINAHL® Plus with Full Text ADVERTISING QUERIES should be addressed to Robert Dougherty, President/Group Publisher, Psychiatry 2008, Matrix Medical Communications, 4975 West Chester Pike, PO Box 445, Edgemont, PA 19028-0445. Toll-free: (866) 325-9907; Phone: (610) 325-9905; Fax: (610) 325-9906; E-mail: rdougherty@matrixmedcom.com 4975 West Chester Pike PO Box 445 Edgemont, PA 19028-0445 Copyright © 2008 Matrix Medical Communications. All rights reserved. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the editorial advisory board. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Reprints are available. Contact Matrix Medical Communications for information. Psychiatry 2008 (ISSN 1550-5952) is published 12 times yearly by Matrix Medical Communications and printed by Publishers Press, Shepherdsville, Kentucky. Printed in the United States of America. Amir Kalali, MD Editor, Psychiatry 2008 8 Psychiatry 2008 [ V O L U M E 5, NUMBER 12, DECEMBER]

Table of Contents Feed for the Digital Edition of Psychiatry - December 2008

Psychiatry - December 2008 Editor’s Message Contents Editorial Advisory Board Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysmorphic Disorder Pain, Pain, Go Away: Antidepressants and Pain Management Why Psychotherapy Helps the Patient in Chronic Pain General Medical Drugs Associated with Depression Katatonia: A New Conceptual Understanding of Catatonia and a New Rating Scale Thermoregulation and the Role of Calcium Signalling in Neurotransmission Cognition and Schizophrenia: Is There a Role for Cognitive Assessments in Diagnosis and Treatment? Journal Watch Information for Authors

Psychiatry - December 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.